Caricamento...
Ezetimibe and Improving Cardiovascular Outcomes: Current Evidence and Perspectives
Low-density lipoprotein lowering with statins has convincingly and consistently proven to reduce cardiovascular events in both primary and secondary prevention. However, despite high-dose statin therapy, residual cardiovascular risk remains and many patients also do not tolerate statins. Ezetimibe w...
Salvato in:
| Pubblicato in: | Cardiol Res Pract |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Hindawi
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7338976/ https://ncbi.nlm.nih.gov/pubmed/32670636 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/9815016 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|